Low dose synthetic human atrial natriuretic peptide infusion in a patient with mitral stenosis and severe pulmonary hypertension.
The present report concerns a case of very low plasma levels of atrial natriuretic peptide (ANP) accompanying severe pulmonary hypertension due to mitral stenosis. There was remarkable fibrosis in the atrium and ANP secretion may have been insufficient. Low-dose infusion (0.025 microg kg(-1) min(-1)) of synthetic human alpha-ANP infusion was very effective in improving the pulmonary hypertension.
Maeda
K
K
First Department of Internal Medicine, Shiga University of Medical Science, Tsukinowa Seta, Otsu, Japan.
Tsutamoto
T
T
Wada
A
A
Hisanaga
T
T
Nishimura
T
T
Yamada
H
H
Sasaki
Y
Y
Kinoshita
M
M
D009320:Atrial Natriuretic Factor / Q000008:administration & dosage* / Q000097:blood; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology* / Q000628:therapy; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000150:complications* / Q000188:drug therapy* / Q000628:therapy; D011669:Pulmonary Wedge Pressure; D013997:Time Factors
D009320:Atrial Natriuretic Factor